CDC Recommends ZOSTAVAX®, Merck’s Shingles Vaccine, For All Appropriate Adults Aged 60 And Older

The U.S. Centers for Disease Control and Prevention (CDC) has adopted the unanimous recommendation of its Advisory Committee on Immunization Practices (ACIP) for the use of ZOSTAVAX® (Zoster Vaccine Live) for the prevention of shingles in adults aged 60 and older. ZOSTAVAX is the only vaccine to prevent shingles, a frequently painful disease marked by a blistering rash that is caused by the reactivation of the chickenpox virus.

More: continued here

Filed under: Immune System / Vaccines on May 22nd, 2008